Tigulixostat (IBI128) vs Febuxostat in Gout — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tigulixostat (IBI128) vs Febuxostat in Gout — Stella

Recruiting

Back to Gout trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai Fudan University HuaShan Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Innovent Biologics Technology Limited (Shanghai R&D Center)

Enrollment target

~600 participants

Started

March 2026

Primary completion

April 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov